Promoting blood circulation for removing blood stasis therapy for acute intracerebral hemorrhage: A systematic review and meta-analysis

Acta Pharmacologica Sinica

Volumn 36, Issue 6, 2015, Pages 659-675

  Li, Hui Qin ^a   Wei, Jing Jing ^a   Xia, Wan ^a   Li, Ji Huang ^a   Liu, Ai Ju ^a   Yin, Su Bing ^a   Wang, Chen ^a   Song, Liang ^a   Wang, Yan ^a   Zheng, Guo Qing ^a   Fan, Ji Ping ^b  

^a WENZHOU MEDICAL UNIVERSITY   (China)

^b INSTITUTE OF CHINESE MATERIA MEDICA   (China)

Author keywords

Acute intracerebral hemorrhage; Meta analysis; Promoting blood circulation for removing blood stasis; Systematic review; Traditional Chinese medicine

Indexed keywords

ASTRAGALUS ROOT; BUYANG HUANWU DECOCTION; CHINESE DRUG; FUFANG DANSHEN INJECTION; HERBACEOUS AGENT; LIANGXUE TONGYU FORMULA; PAEONIA RADIX; PLACEBO; UNCLASSIFIED DRUG; XUESHUANTONG INJECTION; DRUG COMBINATION;

ADJUVANT THERAPY; BARTHEL INDEX; BLOOD VOLUME; BRAIN EDEMA; BRAIN HEMATOMA; BRAIN HEMORRHAGE; CCNDS SCORE; CHINESE MEDICINE; CIRCULATION; CLINICAL ASSESSMENT; CLINICAL EFFECTIVENESS; CLINICAL TRIAL (TOPIC); CNKI DATABASE; COCHRANE LIBRARY; DATA BASE; DATA COLLECTION METHOD; EMBASE; HEMOSTASIS; HERB; HERBAL MEDICINE; HUMAN; LEECH; MEDLINE; META ANALYSIS; MONOTHERAPY; MORTALITY; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; NEUROLOGIC DISEASE; OUTCOME ASSESSMENT; PATIENT SAFETY; PLANT ROOT; PRESCRIPTION; PROMOTING BLOOD CIRCULATION FOR REMOVING BLOOD STASIS THERAPY; QUALITY CONTROL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK ASSESSMENT; SALVIA MILTIORRHIZA; SAMPLE SIZE; SCORING SYSTEM; STROKE PATIENT; SYSTEMATIC REVIEW; TREATMENT OUTCOME; WANFANG DATABASE; BRAIN CIRCULATION; CEREBRAL HEMORRHAGE; CHI SQUARE DISTRIBUTION; DRUG COMBINATION; DRUG EFFECTS; EVIDENCE BASED MEDICINE; HEMATOMA; ODDS RATIO; PATHOPHYSIOLOGY; PROCEDURES; RISK FACTOR;

CEREBRAL HEMORRHAGE; CEREBROVASCULAR CIRCULATION; CHI-SQUARE DISTRIBUTION; DRUG COMBINATIONS; DRUGS, CHINESE HERBAL; EVIDENCE-BASED MEDICINE; HEMATOMA; HUMANS; MEDICINE, CHINESE TRADITIONAL; ODDS RATIO; RISK FACTORS; TREATMENT OUTCOME;

EID: 84930675422     PISSN: 16714083     EISSN: 17457254     Source Type: Journal    
DOI: 10.1038/aps.2014.139     Document Type: Review

References (63)

1. Qureshi AI, Mendelow AD, Hanley DF. Intracerebral haemorrhage. Lancet 2009; 373: 1632-44.
2. van Asch CJ, Luitse MJ, Rinkel GJ, van der Tweel I, Algra A, Klijn CJ. Incidence, case fatality, and functional outcome of intracerebral haemorrhage over time, according to age, sex, and ethnicorigin: a systematic review and meta-analysis. Lancet Neurol 2010; 9: 167-76 .
3. Liu L, Wang D, Wong KS, Wang Y. Stroke and stroke care in China: huge burden, significant workload, and a national priority. Stroke 2011; 42: 3651-4.
4. Tsai CF, Thomas B, Sudlow CL. Epidemiology of stroke and its subtypes in Chinese vs white populations: a systematic review. Neurology 2013; 81: 264-72.
5. Morgenstern LB, Hemphill JC 3rd, Anderson C, Becker K, Broderick JP, Connolly ES Jr, et al. American heart association stroke council and council on cardiovascular nursing. Guidelines for the management of spontaneous intracerebral hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2010; 41: 2108-29.
6. Mendelow AD, Gregson BA, Rowan EN, Murray GD, Gholkar A, Mitchell PM, et al. Early surgery versus initial conservative treatment in patients with spontaneous supratentorial lobar intracerebral haematomas (STICH II): a randomised trial. Lancet 2013; 382: 397-408.
7. Toyoda K, Steiner T, Epple C, Kern R, Nagayama M, Shinohara Y, et al. Comparison of the European and Japanese guidelines for the acute management of intracerebral hemorrhage. Cerebrovasc Dis 2013; 35: 419-29.
8. Mayer SA, Brun NC, Begtrup K, Broderick J, Davis S, Diringer MN, et al. Effcacy and safety of recombinant activated factor VII for acute intracerebral hemorrhage. New Engl J Med 2008; 358: 2127-37.
9. Wang Y, Fan YC, Xie CL, Zheng GQ. History of post-stroke epilepsy in ancient China. J Neurol 2011; 258: 1555-8.
10. Zheng GQ, Huang PX. Origin and development of hemorrhagic stroke. Chin J Med Hist 2005; 35: 25-8.
11. Chen KJ. Blood stasis syndrome and its treatment with activating blood circulation to remove blood stasis therapy. Chin J Integr Med 2012; 18: 891-6.
12. Choi T Y, Jun JH, Lee JA, Park B, You S, Jung J, et al. Expert opinions on the concept of blood stasis in China: an interview study. Chin J Integr Med 2014. doi: 10.1007/s11655-014-1983-3.
13. Li HQ, Liu AJ, Xia W, Li JH, Wei JJ, Yin SB, et al. Promoting blood circulation for removing blood stasis as therapy for acute intracerebral hemorrhage: a systematic review and meta-analysis [database on the Internet]. York: University of York (UK). c2014 - [cited 2014 Jun 18]. Available from: http://www.crd.york.ac.uk/PROSPERO/display-record. asp?ID=CRD42014009003
14. Higgins JP, Gøtzsche PC, Jüni P, Moher D, Oxman AD, Savovic J, et al. The cochrane collaboration's tool for assessing risk of bias in randomised trials. BMJ 2011; 343: d5928.
15. Chung JH, Lee JW, Jo JK, Kim KS, Lee SW. A quality analysis of randomized controlled trials about erectile dysfunction. World J Mens Health 2013; 31: 157-62.
16. Chen QT. Classifcation, diagnostic criteria and evaluation of neurological impairment for stroke patients. Chin J Neurol 1996; 29: 379.
17. Cochrane.org [www.cochrane-handbook.org]. London: The Cochrane Collaboration (UK); c2008 [updated March 2011; cited 2014 Jun 18]. Available from: www.cochrane-handbook.org
18. Guyatt G, Oxman AD, Sultan S, Brozek J, Glasziou P, et al. GRADE guidelines: 11. Making an overall rating of confidence in effect estimates for a single outcome and for all outcomes. J Clin Epidemiol 2013; 66: 151-7.
19. Sun JH, Chen W. Clinical study of minimally traumatic puncture drainage of hematoma combined with Salviae Miltiorrhizae injection in treatment of hypertensive cerebral hemorrhage. Chin J Integr Tradit And Western Med 2008; 15: 28-30. Chinese.
20. Dai MX, Xiao YJ, Wang JP, Xiao HL, Tang CH, et al. Clinical effcacy of zhuyuxiaozhong decoction combined with Stereotactic microsurgery therapy in treating hypertensive cerebral hemorrhage. J New Chin Med 2002; 3: 40-2. Chinese.
21. Huang JL, Li YH, Lin ZP. Therapeutic effcacy of stereotactic microsurgery combined with therapy of inducing resuscitation, activating blood and promoting diuresis in treating severe cerebellopontine hemorrhage. J Guangzhou Univ Tradit Chin Med 2010; 27: 445-8. Chinese.
22. Chen SH, Zhang XY, Li XG, Wang J, Long CG, Xiong Y, et al. Clinical effcacy of zhongfengxingnao oral solution in Chinese subjects with acute cerebral hemorrhage: a randomized, double-blind, placebo-controlled trial [database on the Internet]. Beijing: Tsinghua Tongfang Knowledge Network Technology Co, Ltd. c2010 - [cited 2014 Jun 18]. Available from: http://cpfd.cnki.com.cn/Article/CPFDTOTAL-ZHZY201008004006.htm.
23. He D, Liu QR, Zhao JX. Therapeutic effcacy of xueshuantong injection on patients with acute intracerebral hemorrhage in early stage. Chin J Integr Tradit And West Med Intens and Crit Care 2002; 9: 27-9. Chinese.
24. Fan Y, Zhou ZY, Jin MW. The infuence of liangxuetongyu oral solution on early rehabilitation of hypertensive cerebral hemorrhage. Chin J Integr Tradit West Med 2000; 20: 138-40. Chinese.
25. Wang YQ, Shi Q, Wang WP. Clinical study of xuefuzhuyu decoction on hypertensive intracerebral hemorrhage. J Emerg Tradit Chin Med 2013; 22: 1686-7, 1689. Chinese.
26. Zhang SQ, Zhang CP, Chen ML, Xu XY, Hou B. Clinical study of bushenhuoxuehuatan decoction on acute cerebral hemorrhage. J Emerg Tradit Chin Med 2012; 4: 529-30, 557. Chinese.
27. Wang ZF, Wang JY. Effcacy observation of the sequential therapy of traditional Chinese medicine for hypertensive cerebral hemorrhage. China Pharm 2011; 3: 263-5. Chinese.
28. Ministry of Health of the People's Republic of China. Clinical guideline of new drugs for traditional Chinese medicine. 1993. 35-6.
29. De Angelis C, Drazen JM, Frizelle FA, Haug C, Hoey J, et al. International Committee of Medical Journal Editors. Clinical trial registration: a statement from the International Committee of Medical Journal. New Engl J Med 2004; 351: 1250-1.
30. Kjaergard LL, Villumsen J, Gluud C. Reported methodologic quality and discrepancies between large and small randomized trials in meta-analyses. Ann Intern Med 2001; 135: 982-9.
31. Kotsirilos V. Complementary and alternative medicine. Part 2-evidence and implications for GPs. Aust Fam Physician 2005; 34: 689-91.
32. Meng LQ, Huang RY, Zhu CL, Wei SG, Li XB, Huang JM. The effect of Panax Notoginseng Saponins on expression of AQP4 and brain edema after intracerebral hemorrhage in rats. Chin J Geriatr Heart Brain Vessel Dis 2007; 9: 53-6. Chinese.
33. Zhao XS, Chen ZG, Gao F, Xu ZF. Effect of Panax Notoginseng saponins on cerebral water content and thrombin of intracerebral hemorrhage rats. Chin J Inform on TCM 2014; 21: 46-8. Chinese.
34. Zhu JH, Wang DK, Dong KQ, Dai XW, He LF. Effects of total panax notoginseng saponins on ultrastructure of mitochondria for intra-cerebral hemorrhage focus in rats. Chin J Neuroanat 2014; 30: 60-4. Chinese.
35. Si YC, Li JW, Zhu PC, Zhang LJ. Effects of Panax Notoginseng saponins on expression of excitatory amino acid receptor GluR2 subunit of AMPA receptor in rat forebrain after intracerebral hemorrhage. Chin J Anat 2005; 28: 535-8. Chinese.
36. Zhang ZZ, Zhang BH, Chen M. The study of Danshen Injection for prevention and treatment of brain edema in acute intracerebral hemorrhage. Zhejiang J Integr Tradit Chin West Med 2003; 13: 355-7. Chinese.
37. Liu HY, Zhang HY, Ma QR, Wang DK, Sun Z, Han JL, et all. Effect of Danshen Injection on neurons apoptosis that surround intracerebral hemorrhage in rats. Chin Tradit Patent Med 2012; 34: 731-3. Chinese.
38. He YP, Huang JZ, Ying RB, Pan GC. Study on correlation of thrombin and cerebral edema following intracerebral hemorrhage and effects of treated with hirudo powder. Chin J Emerg Med 2002; 11: 172-5. Chinese.
39. Wu Q, Chen GH, Yang F, Chen ZW. Pathological study of treatment effect of hirudo on experimental intracerebral hemorrhage. J Clin Exp Pathol 1999; 15: 51-3. Chinese.
40. Wang DK, Zhang HY, Sun Z, Liu HY, Li Q, Zhang LX, et al. Effects of Ginkgo Biloba extract on apoptotic neurons around the early hematoma after intracerebral hemorrhage in rats. J Ningxia Med Univ 2011; 33: 537-9. Chinese.
41. Ke JF, Du QC, Zhang HY, Qin Y, Li L, Li Q. Effects of injection of ginkgo biloba leave extract on content of IL-8 and ICAM-1in brain of intracerebral hemorrhage in rats. Ningxia Med J 2010; 32: 46-8. Chinese.
42. Hu JH, Chen HJ, Liu HY, Che P, Qing Y, Zhang LX. The protective effect of erigeron on hemorrhagic brain injury in rats. Chin J Neuroanat 2013; 29: 209-13. Chinese.
43. Dai XW, Zhang HY, Wang DK, Qin Y, Zhang Y. Effects of Breviscapine on cerebral edema and expression of intercellular adhension molecular-1 in rats of cerebral hemorrhage. Chin J Neuroanat 2011; 27: 665-9. Chinese.
44. Sun H, Guo FQ, Wang DZ, Zhang HY, Wang JY. Effects of Buyang Huanwu decoction on expression of aquaporin-4 in brain tissue of intracerebral hemorrhage rats. J Clin Neurol (China) 2012; 25: 115-8. Chinese.
45. Luo JK, Tang T, Li XQ. Effect of Buyang Huanwu decoction on activated caspase-3 after intracerebral hemorrhage in rats. J Tradit Chin Med Univ Hunan 2006; 26: 12-4. Chinese.
46. Liu XJ, Tang T, Luo JK, Huang JF, Yang QD, Xing ZH, et al. Effect of Buyang Huanwu decoction on expression of VEGF mRNA in rat brains following cerebral hemorrhage. Tradit Chin Drug Res Clin Pharmacol 2007; 18: 100-3. Chinese.
47. He CY, Huang JH, Zhou XP, Jin MW, Ye F, Wu HT, et al. Effect of Liangxue Tongyu Formula on t-PA and MMP-9 expressions in rats with intracerebral hemorrhage. Chin J Tradit Chin Med Pharm 2011; 26: 50-3. Chinese.
48. He CY, Huang JH, Wang WJ, Jin MW, Ye F, Wu HT, et al. Effect of Liangxue Tongyu Formula on brain edema and expressions of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in rats with intracerebral hemorrhage. J Chin Integr Med 2010; 8: 347-51. Chinese.
49. Davis SM, Broderick J, Hennerici M, Brun NC, Diringer MN, Mayer SA, et al. Hematoma growth is a determinant of mortality and poor outcome after intracerebral hemorrhage. Neurology 2006; 66: 1175-81.
50. Wada R, Aviv RI, Fox AJ, Sahlas DJ, Gladstone DJ, Tomlinson G, et al. CT angiography "spot sign" predicts hematoma expansion in acute intracerebral hemorrhage. Stroke 2007; 38: 1257-62.
51. Nie YX, Wang D, Zhang X. Effect of panax notoginseng saponins injection on brain edema in intracerebral hemorrhage rats. Chin J Integr Tradit West Med 2006; 26: 922-5. Chinese
52. Xue M, Hollenberg MD, Demchuk A, Yong VW. Relative importance of proteinase-activated receptor-1 versus matrix metalloproteinases in intracerebral hemorrhage-mediated neurotoxicity in mice. Stroke 2009; 40: 2199-204.
53. Guangzhou University of Traditional Chinese Medicine. Clinical reevaluation of removing blood stasis therapy in treating acute cerebral hemorrhage safety and effcacy [database on the Internet]. Bethesda: National Library of Medicine (US). c2013 - [cited 2014 Jun 18]. Available from: http://clinicaltrials.gov/show/NCT01918722
54. Wang J, Xiong X. Current situation and perspectives of clinical study in integrative medicine in china. Evid Based Complement Alternat Med 2012; 2012: 268542.
55. Jiang M, Lu C, Zhang C, Yang J, Tan Y, Lu A, et al. Syndrome differentiation in modern research of traditional Chinese medicine. J Ethno-pharmacol 2012; 140: 634-42.
56. Bensoussan A, Talley NJ, Hing M, Menzies R, Guo A, Ngu M. Treatment of irritable bowel syndrome with Chinese herbal medicine: a randomized controlled trial. JAMA 1998; 280: 1585-9.
57. Li SM, Xu H, Chen KJ. The diagnostic criteria of blood-stasis syndrome: considerations for standardization of pattern identifcation. Chin J Integr Med 2014; 20: 483-9.
58. Lu A, Jiang M, Zhang C, Chan K. An integrative approach of linking traditional Chinese medicine pattern classifcation and biomedicine diagnosis. J Ethnopharmacol 2012; 141: 549-56.
59. Wang L, Yuan Q, Marshall G, Cui X, Cheng L, Li Y, et al. Adverse drug reactions and adverse events of 33 varieties of traditional Chinese medicine injections on national essential medicines List (2004 edition) of China: an overview on published literatures. J Evid Based Med 2010; 3: 95-104.
60. Bian ZX, Tian HY, Gao L, Shang HC, Wu TX, Li YP, et al. Improving reporting of adverse events and adverse drug reactions following injections of Chinese materia medica. J Evid Based Med 2010; 3: 5-10.
61. Schulz KF, Altman DG, Moher D; CONSORT Group. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. J Clin Epidemiol 2010; 63: 834-40.
62. Flower A, Witt C, Liu JP, Ulrich-Merzenich G, Yu H, Lewith G. Guidelines for randomised controlled trials investigating Chinese herbal medicine. J Ethnopharmacol 2012; 140: 550-4.
63. Bian Z, Liu B, Moher D, Wu T, Li Y, Shang H, et al. Consolidated standards of reporting trials (CONSORT) for traditional Chinese medicine: current situation and future development. Front Med 2011; 5: 171-7.